Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Ono Pharmaceutical Co., Ltd.    4528   JP3197600004

ONO PHARMACEUTICAL CO., LTD.

(4528)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Tokyo Stock Exchange
08/03/2020 08/04/2020 08/05/2020 08/06/2020 08/07/2020 Date
3072 3051 3035 3028 3031 Last
1477400 1867100 775200 806800 902600 Volume
+3.66% -0.68% -0.52% -0.23% +0.10% Change
Financials
Sales 2021 308 B 2 911 M 2 911 M
Net income 2021 65 418 M 618 M 618 M
Net cash position 2021 121 B 1 139 M 1 139 M
P/E ratio 2021 23,3x
Yield 2021 1,60%
Sales 2022 342 B 3 226 M 3 226 M
Net income 2022 78 652 M 742 M 742 M
Net cash position 2022 145 B 1 364 M 1 364 M
P/E ratio 2022 19,3x
Yield 2022 1,79%
Capitalization 1 513 B 14 293 M 14 282 M
EV / Sales 2021 4,51x
EV / Sales 2022 4,00x
Nbr of Employees 3 560
Free-Float 75,6%
More Financials
Company
ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development, introduction and derivation of pharmaceuticals. 
More about the company
Surperformance© ratings of Ono Pharmaceutical Co., Lt
Trading Rating : Investor Rating :
More Ratings
Latest news on ONO PHARMACEUTICAL CO., LT
07/31ONO PHARMACEUTICAL : Development of Therapeutic Drugs for Novel Coronavirus Infe..
AQ
07/27THEN YOU DIDN'T SEE THEM; NOW YOU DO : Co-Inventors Added
AQ
07/24ONO PHARMACEUTICAL : Independently Performed, Publicly Disclosed Prior Work Can ..
AQ
07/22ONO PHARMACEUTICAL : Federal Circuit Confirms Joint Inventorship On Nobel Prize ..
AQ
07/22ONO PHARMACEUTICAL : Federal Circuit Confirms Joint Inventorship On Nobel Prize ..
AQ
07/17ONO PHARMACEUTICAL : Federal Circuit Confirms Addition Of Two Inventors Of Groun..
AQ
07/15ONO PHARMACEUTICAL : Selected for 'MSCI Japan ESG Select Leaders Index' for the ..
AQ
07/15ONO PHARMACEUTICAL : Support for Relief Efforts to the Disaster Caused by Heavy ..
AQ
07/07ONO PHARMACEUTICAL : Notice regarding Filing an Appeal for a Lawsuit against the..
AQ
07/06ONO PHARMACEUTICAL : Notice Concerning Determination of Details of Issuance of S..
AQ
06/30ONO PHARMACEUTICAL : Receives a Manufacturing and Marketing Approval in Japan of..
AQ
06/30ONO PHARMACEUTICAL : A Short-Acting Selective 1 Blocker, Onoact for Intravenous ..
AQ
06/19ONO PHARMACEUTICAL : Nobel laureate Honjo sues Ono Pharmaceutical over patent ro..
AQ
06/12ONO PHARMACEUTICAL : and Seikagaku Announce the Results from a Phase III Clinica..
AQ
06/08ONO PHARMACEUTICAL : Joins RE100, an International Initiative Aiming to Use 100%..
AQ
More news
News in other languages on ONO PHARMACEUTICAL CO., LT
07/31ONO PHARMACEUTICAL : Development of Therapeutic Drugs for Novel Coronavirus Infe..
07/27THEN YOU DIDN'T SEE THEM; NOW YOU DO : Co-Inventors Added
07/24ONO PHARMACEUTICAL : Independently Performed, Publicly Disclosed Prior Work Can ..
07/22ONO PHARMACEUTICAL : Federal Circuit Confirms Joint Inventorship On Nobel Prize ..
07/22ONO PHARMACEUTICAL : Federal Circuit Confirms Joint Inventorship On Nobel Prize ..
More news
Chart ONO PHARMACEUTICAL CO., LTD.
Duration : Period :
Ono Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ONO PHARMACEUTICAL CO., LT
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 3 166,92 JPY
Last Close Price 3 031,00 JPY
Spread / Highest target 22,7%
Spread / Average Target 4,48%
Spread / Lowest Target -17,5%
EPS Revisions
Managers
NameTitle
Gyo Sagara President & Representative Director
Toichi Takino Managing Executive Officer & GM-Research
Kazuhito Kawabata Director & Managing Executive Officer
Hiroshi Awata Director & Executive Vice President
Isao Ono Director & Managing Executive Officer